Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionResources Management Corp /ct/ /adv
Latest Disclosed Ownership65,853 shares
Latest Disclosed Value $ 6,761
Resources Management Corp /ct/ /adv reports 23.88% increase in ownership of ABL / Abbott Laboratories

On May 15, 2026 - Resources Management Corp /ct/ /adv filed a 13F-HR form disclosing ownership of 65,853 shares of Abbott Laboratories (DE:ABL) valued at $5,849,063 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 53,158 shares of Abbott Laboratories. This represents a change in shares of 23.88% during the quarter. The current value of the position is $4,953,463 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 65,853 12,695 23.88 7 0.00 0.8974
2026-02-13 2025-12-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 53,158 257 0.49 7 -14.29 0.8628
2025-11-14 2025-09-30 13F/A-1 ABBOTT LABORATORIES Ordinary Share 002824100 52,901 -1,312 -2.42 7 0.00 0.9158
2025-11-14 2025-09-30 13F AIR PRODUCTS & CHEMICALS Ordinary Share 002824100 14,127 -40,086 4 0.4978
2025-08-15 2025-06-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 54,213 -100 -0.18 7 0.00 1.0012
2025-05-16 2025-03-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 54,313 -1,134 -2.05 7 16.67 1.0132
2025-02-14 2024-12-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 55,447 -1,745 -3.05 6 0.00 0.8561
2024-11-15 2024-09-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 57,192 -3,535 -5.82 7 0.00 0.8796
2024-08-14 2024-06-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 60,727 522 0.87 6 0.00 0.9184
2024-05-15 2024-03-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 60,205 -4,818 -7.41 7 -14.29 1.0000
2024-02-14 2023-12-31 13F/A-1 ABBOTT LABORATORIES Ordinary Share 002824100 65,023 111 0.17 7 16.67 1.0632
2024-02-14 2023-12-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 110 7
2023-11-16 2023-09-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 64,912 738 1.15 6 0.00 1.0237
2023-08-16 2023-06-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 64,174 64,074 64,074.00 7 1.0918
2023-05-11 2023-03-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 100 -63,407 -99.84 0 -100.00 0.0003
2023-02-08 2022-12-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 63,507 1,636 2.64 7 -99.90 1.1008
2022-11-15 2022-09-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 61,871 2,886 4.89 5,987 -6.58 1.0331
2022-08-10 2022-06-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 58,985 1,599 2.79 6,409 -5.64 1.0357
2022-05-20 2022-03-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 57,386 -133 -0.23 6,792 -16.10 0.9490
2022-02-04 2021-12-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 57,519 825 1.46 8,095 20.88 1.0534
2021-11-12 2021-09-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 56,694 171 0.30 6,697 2.20 0.9628
2021-08-10 2021-06-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 56,523 6,112 12.12 6,553 8.48 0.9204
2021-05-13 2021-03-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 50,411 -257 -0.51 6,041 8.89 0.9133
2021-02-16 2020-12-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 50,668 -675 -1.31 5,548 -0.72 0.8924
2020-11-12 2020-09-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 51,343 -5 -0.01 5,588 19.02 1.0088
2020-08-11 2020-06-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 51,348 -150 -0.29 4,695 15.53 0.8980
2020-05-04 2020-03-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 51,498 -1,645 -3.10 4,064 -11.96 0.9065
2020-02-13 2019-12-31 13F ABBOTT LABORATORIES Ordinary Share 002824100 53,143 -550 -1.02 4,616 2.76 0.7994
2019-12-04 2019-09-30 13F ABBOTT LABORATORIES Ordinary Share 002824100 53,693 -500 -0.92 4,492 16.10 0.8309
2019-02-21 2018-12-31 13F ABBOTT LABORATORIES Ordinary Shares 002824100 54,193 -1,435 -2.58 3,869 -5.17 0.8611
2018-11-15 2018-09-30 13F ABBOTT LABORATORIES Ordinary Shares 002824100 55,628 55,628 4,080 0.7442
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.